Back to BlackRock, Inc. BlackRock, Inc.

ELDNELDN
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ELEDON PHARMACEUTICALS INC

BlackRock, Inc. holds 5.1M shares of ELDN (ELEDON PHARMACEUTICALS INC), worth $20.2M as of 2026-Q2. The position was increased (+16.9% shares). ELDN represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$20.2M

Current Shares

5.1M

Total Value Change

+$17.6M

Total Shares Change

+4.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.1M
+16.9%
$20.2M0.0%$3.94
33
2026-Q1
Increased
4.4M
+20.8%
$13.5M0.0%$2.50
33
2025-Q4
Increased
3.6M
+4.7%
$5.5M0.0%$1.51
28
2025-Q3
Increased
3.5M
+6.5%
$9M0.0%$2.54
29
2025-Q2
Increased
3.3M
+398.6%
$8.8M0.0%$2.69
44
2025-Q1
Increased
652,621
+5.7%
$2.2M0.0%$3.35
19
2024-Q4
New
617,624
-
$2.5M0.0%$4.14
36

Other major holders of ELDN: RA CAPITAL MANAGEMENT, L.P., VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used